At a glance
ClinicalIndex Comparison RecordN/ACompleted· 9,559 enrolled
Drug / intervention
Non-interventionalother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Treatment of High and Very High riSk Dyslipidemic pAtients for the PreveNTion of CardiOvasculaR Events in Europe - a MultInatioNal ObservatIonal Study (SANTORINI)
Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company·observational·Posted Feb 17, 2020·Updated Feb 20, 2024
In Brief
An observational study evaluating Non-interventional for Dyslipidemia and 3 related conditions. Completed, enrolled 9,559 participants across 540 sites in 14 countries.
Detailed Summary
High and Very High Risk cardiovascular patient journeys seems to vary from country to country, and current understanding of the process is incomplete. This real-life observational study which documents meaningful patient journey-related parameters can be expected to provide meaningful insight into the care process, country-by-country.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsDyslipidemia, Cardiovascular Diseases, Hypercholesterolemia, Atherosclerotic Cardiovascular Disease
CountriesAustria, Belgium, Denmark, Finland, France, Germany, Ireland, Italy, Netherlands, Portugal, Spain, Sweden, Switzerland, United Kingdom
Collaborators--
Timeline
N/ACompletedFinished
2020202120222023202420252026
First PostedFeb 2020
Enrollment StartMar 2020
Primary CompletionApr 2022
TodayJul 2026
First PostedFeb 17, 2020
Enrollment StartMar 17, 2020
Primary CompletionApr 11, 2022
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 6.4 years ago
Interventions
Non-interventionalother
This is a non-interventional study.